当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:503.73亿  总市值:503.73亿
流通股本:12.64亿   总股本:12.64亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金428,230,392.312,438,221,560.561,803,955,458.741,090,752,777.2
  收到的税费返还-1,489,586.8117,053.733,068.48
  收到其他与经营活动有关的现金48,814,241.98139,241,305.72117,080,445.6878,865,735.82
  经营活动现金流入小计477,044,634.292,578,952,453.091,921,052,958.151,169,621,581.5
  购买商品、接受劳务支付的现金144,578,081.77643,215,533.89419,100,138.2263,620,598.96
  支付给职工以及为职工支付的现金352,833,940.71,034,628,104.58798,829,410.92574,836,717.51
  支付的各项税费59,140,142.78164,693,486.34107,439,584.9280,202,387.88
  支付其他与经营活动有关的现金152,536,705.67646,661,285.18588,399,269.44317,515,282.71
  经营活动现金流出小计709,088,870.922,489,198,409.991,913,768,403.481,236,174,987.06
  经营活动产生的现金流量净额-232,044,236.6389,754,043.17,284,554.67-66,553,405.56
二、投资活动产生的现金流量:
  收回投资收到的现金3,526,131,777.474,647,311,628.273,984,425,204.452,218,505,760
  取得投资收益收到的现金97,123,533.24114,450,861.91102,983,184.4349,474,203.3
  处置固定资产、无形资产和其他长期资产收回的现金净额1,623210,726,017.0548,990.8544,768.85
  收到的其他与投资活动有关的现金-5,775,292.24302,022.04-
  投资活动现金流入小计3,623,256,933.714,978,263,799.474,087,759,401.772,268,024,732.15
  购建固定资产、无形资产和其他长期资产支付的现金100,204,503.7805,164,493.44557,471,858.41432,022,484.44
  投资支付的现金-4,929,122,930.22923,443.68-
  支付其他与投资活动有关的现金3,207,504,427.92,985,107.83,606,361,2002,335,361,200
  投资活动现金流出小计3,307,708,931.65,737,272,531.464,164,756,502.092,767,383,684.44
  投资活动产生的现金流量净额315,548,002.11-759,008,731.99-76,997,100.32-499,358,952.29
三、筹资活动产生的现金流量:
  取得借款收到的现金67,370,265.08343,558,490.81249,073,800.99119,383,754.94
  收到其他与筹资活动有关的现金-299.26-2,851,954.561,214,782.56
  筹资活动现金流入小计67,369,965.82343,558,490.81251,925,755.55120,598,537.5
  偿还债务支付的现金58,454,271.17319,007,771.34231,825,639.41160,733,219.5
  分配股利、利润或偿付利息支付的现金222,620.032,277,526.661,314,939.151,082,833.08
  支付其他与筹资活动有关的现金1,434,098.221,801,532.27,601,461.635,565,057.08
  筹资活动现金流出小计60,110,989.4343,086,830.2240,742,040.19167,381,109.66
  筹资活动产生的现金流量净额7,258,976.42471,660.6111,183,715.36-46,782,572.16
四、汇率变动对现金及现金等价物的影响-12,590,723.87-13,270,093.55-4,670,237.65-891,741.35
五、现金及现金等价物净增加额78,172,018.03-682,053,121.83-63,199,067.94-613,586,671.36
  加:期初现金及现金等价物余额1,344,952,704.672,027,005,826.52,027,005,826.52,027,005,826.5
  期末现金及现金等价物余额1,423,124,722.71,344,952,704.671,963,806,758.561,413,419,155.14
补充资料:
  净利润--413,963,529.44--145,492,229.78
  资产减值准备-207,361,022.12-23,426,159.84
  固定资产和投资性房地产折旧-262,816,779.48-126,633,472.93
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-262,816,779.48-126,633,472.93
  无形资产摊销-53,278,499.24-19,133,905.37
  长期待摊费用摊销-21,725,256.4-10,394,548.6
  处置固定资产、无形资产和其他长期资产的损失--60,231,327.31-146,644.6
  固定资产报废损失-2,193,208.09-1,117,276.03
  公允价值变动损失--48,297,071.98--17,591,273.78
  财务费用-14,660,009.6-3,408,049.43
  投资损失--66,215,195.97--44,357,628.65
  递延所得税--94,845,344.69--8,191,106.5
  其中:递延所得税资产减少--94,845,344.69--8,191,106.5
  存货的减少--40,540,197.18--110,937,022.61
  经营性应收项目的减少-398,160,460.04-140,006,200.46
  经营性应付项目的增加--183,403,743.15--142,749,151.44
  其他--14,145,472.91--
  不涉及现金收支的投资和筹资活动金额其他项目-8,341,962.59--
  现金的期末余额-1,344,952,704.67-1,413,419,155.14
  减:现金的期初余额-2,027,005,826.5-2,027,005,826.5
  现金及现金等价物的净增加额--682,053,121.83--613,586,671.36
公告日期2026-04-282026-04-212025-10-302025-08-21
审计意见(境内)标准无保留意见
TOP↑